mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro

Journal of Lipid Research

Volumn 48, Issue 5, 2007, Pages 1099-1107

  Wang, Hong ^a,c   Edens, Neilé K ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Lipolysis; Phosphodiesterase; Prostaglandin E2

Indexed keywords

CILOSTAMIDE; CYCLIC AMP; ISOPHANE INSULIN; ISOPRENALINE; MESSENGER RNA; PHENYLISOPROPYLADENOSINE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVA; PHOSPHODIESTERASE IVB; PHOSPHODIESTERASE IVC; PHOSPHODIESTERASE IVD; PROSTAGLANDIN E2; ROLIPRAM; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL FRACTIONATION; CELL STIMULATION; CELLULAR DISTRIBUTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG INHIBITION; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; GENE EXPRESSION; HYDROLYSIS; IN VITRO STUDY; LIPOLYSIS; MALE; MONOTHERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADIPOCYTES; ANIMALS; BASE SEQUENCE; DINOPROSTONE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INSULIN; ISOPROTERENOL; LIPOLYSIS; MALE; MOLECULAR SEQUENCE DATA; PHENYLISOPROPYLADENOSINE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEQUENCE ALIGNMENT;

EID: 34248221475     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600519-JLR200     Document Type: Article

References (30)

1. Zimmermann, R., J. G. Strauss, G. Haemmerle, G. Schoiswohl, R. Birner-Gruenberger, M. Riederer, A. Lass, G. Neuberger, F. Eisenhaber, A. Hermetter, et al. 2004. Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science. 306: 1383-1386.
2. Holm, C., T. Osterlund, H. Laurell, and J. A. Contreras. 2000. Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu. Rev. Nutr. 20: 365-393.
3. Houslay, M. D. 2001. PDE4 cAMP-specific phosphodiesterases. Prog. Nucleic Acid Res. Mol. Biol. 69: 249-315.
4. Degerman, E., C. J. Smith, H. Tornqvist, V. Vasta, P. Belfrage, and V. C. Manganiello. 1990. Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation. Proc. Natl. Acad. Sci. USA. 87: 533-537.
5. Smith, C. J., V. Vasta, E. Degerman, P. Belfrage, and V. C. Manganiello. 1991. Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. Regulation of insulinand cAMP-dependent activation by phosphorylation. J. Biol. Chem. 266: 13385-13390.
6. Lonnqvist, F., A. Wennlund, and P. Arner. 1989. Antilipolytic effects of insulin and adenylate cyclase inhibitors on isolated human fat cells. Int. J. Obes. 13: 137-146.
7. Schmitz-Peiffer, C., M. L. Reeves, and R. M. Denton. 1992. Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cells. Cell. Signal. 4: 37-49.
8. Shechter, Y. 1984. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism. Endocrinology. 115: 1787-1791.
9. Elks, M. L., and V. C. Manganiello. 1984. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3′,5′-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes. Endocrinology. 115: 1262-1268.
10. Zhang, X., and G. B. Carey. 2004. Plasma membrane-bound cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 137: 309-316.
11. MacKenzie, S. J., S. J. Yarwood, A. H. Peden, G. B. Bolger, R. G. Vernon, and M. D. Houslay. 1998. Stimulation of p70S6 kinase via a growth hormone-controlled phosphatidylinositol 3-kinase pathway leads to the activation of a PDE4A cyclic AMP-specific phosphodiesterase in 3T3-F442A preadipocytes. Proc. Natl. Acad. Sci. USA. 95: 3549-3554.
12. Wang, H., L. A. Reaves, and N. K. Edens. 2006. Ginseng extract inhibits lipolysis in rat adipocytes in vitro by activating phosphodiesterase 4. J. Nutr. 136: 337-342.
13. Edens, N. K., L. A. Reaves, M. S. Bergana, I. L. Reyzer, P. O'Mara, J. H. Baxter, and M. K. Snowden. 2002. Yeast extract stimulates glucose metabolism and inhibits lipolysis in rat adipocytes in vitro. J. Nutr. 132: 1141-1148.
14. Rodbell, M. 1964. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239: 375-380.
15. Harndahl, L., X. J. Jing, R. Ivarsson, E. Degerman, B. Ahren, V. C. Manganiello, E. Renstrom, and L. S. Holst. 2002. Important role of phosphodiesterase 3B for the stimulatory action of cAMP on pancreatic beta-cell exocytosis and release of insulin. J. Biol. Chem. 277: 37446-37455.
16. Kostic, M. M., S. Erdogan, G. Rena, G. Borchert, B. Hoch, S. Bartel, G. Scotland, E. Huston, M. D. Houslay, and E. G. Krause. 1997. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart. J. Mol. Cell. Cardiol. 29: 3135-3146.
17. Manganiello, V., and M. Vaughan. 1973. An effect of insulin on cyclic adenosine 3′:5′-monophosphate phosphodiesterase activity in fat cells. J. Biol. Chem. 248: 7164-7170.
18. Ahmad, F., G. Gao, L. M. Wang, T. R. Landstrom, E. Degerman, J. H. Pierce, and V. C. Manganiello. 1999. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells. J. Immunol. 162: 4864-4875.
19. Honnor, R. C., G. S. Dhillon, and C. Londos. 1985. cAMP-dependent protein kinase and lipolysis in rat adipocytes. I. Cell preparation, manipulation, and predictability in behavior. J. Biol. Chem. 260: 15122-15129.
20. Ariga, M., B. Neitzert, S. Nakae, G. Mottin, C. Bertrand, M. P. Pruniaux, S. L. Jin, and M. Conti. 2004. Nonredundant function of phosphodiesterases 4D and 4B in neutrophil recruitment to the site of inflammation. J. Immunol. 173: 7531-7538.
21. Liu, H., and D. H. Maurice. 1998. Expression of cyclic GMPinhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP. Br. J. Pharmacol. 125: 1501-1510.
22. Eriksson, H., M. Ridderstrale, E. Degerman, D. Ekholm, C. J. Smith, V. C. Manganiello, P. Belfrage, and H. Tornqvist. 1995. Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim. Biophys. Acta. 1266: 101-107.
23. Snyder, P. B., J. M. Esselstyn, K. Loughney, S. L. Wolda, and V. A. Florio. 2005. The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J. Lipid Res. 46: 494-503.
24. Adler-Wailes, D. C., H. Liu, F. Ahmad, N. Feng, C. Londos, V. Manganiello, and J. A. Yanovski. 2005. Effects of the human immunodeficiency virus-protease inhibitor, ritonavir, on basal and catecholamine-stimulated lipolysis. J. Clin. Endocrinol. Metab. 90: 3251-3261.
25. Fain, J. N., R. H. Pointer, and W. F. Ward. 1972. Effects of adenosine nucleosides on adenylate cyclase, phosphodiesterase, cyclic adenosine monophosphate accumulation, and lipolysis in fat cells. J. Biol. Chem. 247: 6866-6872.
26. Strong, P., R. A. Coleman, and P. P. Humphrey. 1992. Prostanoid-induced inhibition of lipolysis in rat isolated adipocytes: probable involvement of EP3 receptors. Prostaglandins. 43: 559-566.
27. Zaccolo, M., and T. Pozzan. 2002. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 295: 1711-1715.
28. Zmuda-Trzebiatowska, E., A. Oknianska, V. Manganiello, and E. Degerman. 2006. Role of PDE3B in insulin-induced glucose uptake, GLUT-4 translocation and lipogenesis in primary rat adipocytes. Cell. Signal. 18: 382-390.
29. Palmer, D., K. Tsoi, and D. H. Maurice. 1998. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ. Res. 82: 852-861.
30. Bielekova, B., A. Lincoln, H. McFarland, and R. Martin. 2000. Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases. J. Immunol. 164: 1117-1124.